143 related articles for article (PubMed ID: 11343833)
1. Excitotoxic injury stimulates pro-drug-induced 7-chlorokynurenate formation in the rat striatum in vivo.
Lee SC; Schwarcz R
Neurosci Lett; 2001 May; 304(3):185-8. PubMed ID: 11343833
[TBL] [Abstract][Full Text] [Related]
2. In situ produced 7-chlorokynurenate provides protection against quinolinate- and malonate-induced neurotoxicity in the rat striatum.
Guidetti P; Wu HQ; Schwarcz R
Exp Neurol; 2000 May; 163(1):123-30. PubMed ID: 10785450
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the Effects of L-4-Chlorokynurenine on Nociception in Rodents.
Yaksh TL; Schwarcz R; Snodgrass HR
J Pain; 2017 Oct; 18(10):1184-1196. PubMed ID: 28428091
[TBL] [Abstract][Full Text] [Related]
4. Enzyme-catalyzed production of the neuroprotective NMDA receptor antagonist 7-chlorokynurenic acid in the rat brain in vivo.
Wu HQ; Salituro FG; Schwarcz R
Eur J Pharmacol; 1997 Jan; 319(1):13-20. PubMed ID: 9030892
[TBL] [Abstract][Full Text] [Related]
5. Systemic administration of 4-chlorokynurenine prevents quinolinate neurotoxicity in the rat hippocampus.
Wu HQ; Lee SC; Schwarcz R
Eur J Pharmacol; 2000 Mar; 390(3):267-74. PubMed ID: 10708733
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of [5-(3)H]kynurenine in the developing rat brain in vivo: effect of intrastriatal ibotenate injections.
Ceresoli G; Guidetti P; Schwarcz R
Brain Res Dev Brain Res; 1997 May; 100(1):73-81. PubMed ID: 9174248
[TBL] [Abstract][Full Text] [Related]
7. Probenecid Increases the Concentration of 7-Chlorokynurenic Acid Derived from the Prodrug 4-Chlorokynurenine within the Prefrontal Cortex.
Patel W; Rimmer L; Smith M; Moss L; Smith MA; Snodgrass HR; Pirmohamed M; Alfirevic A; Dickens D
Mol Pharm; 2021 Jan; 18(1):113-123. PubMed ID: 33307708
[TBL] [Abstract][Full Text] [Related]
8. Facilitated brain uptake of 4-chlorokynurenine and conversion to 7-chlorokynurenic acid.
Hokari M; Wu HQ; Schwarcz R; Smith QR
Neuroreport; 1996 Dec; 8(1):15-8. PubMed ID: 9051744
[TBL] [Abstract][Full Text] [Related]
9. Modulation of striatal quinolinate neurotoxicity by elevation of endogenous brain kynurenic acid.
Harris CA; Miranda AF; Tanguay JJ; Boegman RJ; Beninger RJ; Jhamandas K
Br J Pharmacol; 1998 May; 124(2):391-9. PubMed ID: 9641558
[TBL] [Abstract][Full Text] [Related]
10. Specific inhibition of kynurenate synthesis enhances extracellular dopamine levels in the rodent striatum.
Amori L; Wu HQ; Marinozzi M; Pellicciari R; Guidetti P; Schwarcz R
Neuroscience; 2009 Mar; 159(1):196-203. PubMed ID: 19138730
[TBL] [Abstract][Full Text] [Related]
11. Protection against quinolinic acid-mediated excitotoxicity in nigrostriatal dopaminergic neurons by endogenous kynurenic acid.
Miranda AF; Boegman RJ; Beninger RJ; Jhamandas K
Neuroscience; 1997 Jun; 78(4):967-75. PubMed ID: 9174065
[TBL] [Abstract][Full Text] [Related]
12. Intrastriatal Quinolinic Acid Administration Impairs Redox Homeostasis and Induces Inflammatory Changes: Prevention by Kynurenic Acid.
Ferreira FS; Schmitz F; Marques EP; Siebert C; Wyse ATS
Neurotox Res; 2020 Jun; 38(1):50-58. PubMed ID: 32219734
[TBL] [Abstract][Full Text] [Related]
13. Protective effect of L-kynurenine and probenecid on 6-hydroxydopamine-induced striatal toxicity in rats: implications of modulating kynurenate as a protective strategy.
Silva-Adaya D; Pérez-De La Cruz V; Villeda-Hernández J; Carrillo-Mora P; González-Herrera IG; García E; Colín-Barenque L; Pedraza-Chaverrí J; Santamaría A
Neurotoxicol Teratol; 2011; 33(2):303-12. PubMed ID: 20933078
[TBL] [Abstract][Full Text] [Related]
14. Kynurenate and 7-chlorokynurenate formation in chronically epileptic rats.
Wu HQ; Rassoulpour A; Goodman JH; Scharfman HE; Bertram EH; Schwarcz R
Epilepsia; 2005 Jul; 46(7):1010-6. PubMed ID: 16026552
[TBL] [Abstract][Full Text] [Related]
15. L-4-chlorokynurenine attenuates kainate-induced seizures and lesions in the rat.
Wu HQ; Lee SC; Scharfman HE; Schwarcz R
Exp Neurol; 2002 Sep; 177(1):222-32. PubMed ID: 12429224
[TBL] [Abstract][Full Text] [Related]
16. Dopamine receptor activation reveals a novel, kynurenate-sensitive component of striatal N-methyl-D-aspartate neurotoxicity.
Poeggeler B; Rassoulpour A; Wu HQ; Guidetti P; Roberts RC; Schwarcz R
Neuroscience; 2007 Aug; 148(1):188-97. PubMed ID: 17629627
[TBL] [Abstract][Full Text] [Related]
17. Metabolism of [5-3H]kynurenine in the rat brain in vivo: evidence for the existence of a functional kynurenine pathway.
Guidetti P; Eastman CL; Schwarcz R
J Neurochem; 1995 Dec; 65(6):2621-32. PubMed ID: 7595559
[TBL] [Abstract][Full Text] [Related]
18. Quinolinic acid lesion of the nigrostriatal pathway: effect on turning behaviour and protection by elevation of endogenous kynurenic acid in Rattus norvegicus.
Miranda AF; Sutton MA; Beninger RJ; Jhamandas K; Boegman RJ
Neurosci Lett; 1999 Mar; 262(2):81-4. PubMed ID: 10203236
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Large Neutral Amino Acid Transporters Suppresses Kynurenic Acid Production Via Inhibition of Kynurenine Uptake in Rodent Brain.
Sekine A; Kuroki Y; Urata T; Mori N; Fukuwatari T
Neurochem Res; 2016 Sep; 41(9):2256-66. PubMed ID: 27161376
[TBL] [Abstract][Full Text] [Related]
20. A mechanism of quinolinic acid formation by brain in inflammatory neurological disease. Attenuation of synthesis from L-tryptophan by 6-chlorotryptophan and 4-chloro-3-hydroxyanthranilate.
Heyes MP; Saito K; Major EO; Milstien S; Markey SP; Vickers JH
Brain; 1993 Dec; 116 ( Pt 6)():1425-50. PubMed ID: 8293279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
